The Innovative Medicines Initiative - ILSI Health and...

Hugh Laverty15th June 2017, HESI ANNUAL MEETING, Dublin

The Innovative Medicines Initiative

IMI Europes partnership for health

Partnership2008 - 2024 2.5 bn

> 5 bn

2.5 bn

IMI2: 2014-20243.3 bn budgetMore ambitious

More openGreater scope

IMI1: 2008-20172 bn budget59 projects

Goals of IMI 2 programme

Improve the drug development process by creating tools to assess the efficacy, safety and quality of medicines

Increase the success rate of clinical trials of new medicines & vaccines

Speed up the earlier stages of drug development

Develop new treatments for areas of unmet need

Develop new biological markers to diagnose diseases and assess treatments

IMI key concepts

Non-competitive collaborative research Competitive Calls for proposals Open collaboration in public-private consortia Data sharing Dissemination of results

Industry contribution is in kind

An international, cross-sector community

970 academic

teams

202 SME teams

552 EFPIA teams

31 patient orgs

108 other teams

Over 9 000 researchers working for: open collaboration improved R&D

productivity innovative approaches

to unmet medical needs

Figures from June 2016

IMI1 budget distribution per disease area

IMI 1

IMI contributions

EFPIA contributions

Budget distribution per disease area Updated January 2017

Infectious diseases 671 635 805

35%

Drug Discovery 214 201 208

11%

Brain disorders 188 239 313 10%

Drug safety 115 383 536 6%

Metabolic disorders 119 468 874 6%

Cancer74 371 979 4%

Data Management 74 291 023 4%

Inflammatory disorders 67 869 654 4%

Vaccines 47 642 719 2%

Geriatrics 47 453 831 2%

Lung diseases 38 499 367 2%

Sustainable chemistry 32 399 640 2%

Education and Training 39 650 498 2%

Stem cells77 380 311 4%

Biologicals 56 023 072 3%

Drug kinetics 18 118 248 1%

Drug Delivery 21 336 248 1%

Relative effectiveness 14 910 397 1%

Total contributions 1 918 875 722

Data

IMICall TopicAcronymDisease AreaIMI contribution euroEFPIA contribution euroAssociated Partners contribution euroTotal contribution euroIMI contribution %EFPIA contribution %Associated Partners contribution %

IMI112MARCARDrug safety6,049,5785,155,60411,205,18254%46%

IMI113eTOXDrug safety6,910,01810,157,59017,067,60840%60%

IMI115SAFE-TDrug safety13,901,97118,326,52132,228,49243%57%

IMI116PROTECTDrug safety11,009,71510,864,49121,874,20650%50%

IMI117IMIDIAMetabolic disorders8,060,76016,940,65925,001,41932%68%

IMI118SUMMITMetabolic disorders14,654,55915,252,05029,906,60949%51%

IMI119EUROPAINBrain disorders6,229,34311,165,74017,395,08336%64%

IMI1110NEWMEDSBrain disorders8,986,21613,789,41222,775,62839%61%

IMI1111PHARMA-COGBrain disorders9,658,38811,690,33321,348,72145%55%

IMI1112U-BIOPREDLung diseases9,935,50114,574,65224,510,15341%59%

IMI1113PRO- ActiveLung diseases6,767,5977,221,61713,989,21448%52%

IMI1115SafeSciMETEducation and Training2,374,9043,607,5405,982,44440%60%

IMI1116PharmaTrainEducation and Training3,510,3003,489,1816,999,48150%50%

IMI1118EU2PEducation and Training3,708,2254,019,6617,727,88648%52%

IMI1114EMTRAINEducation and Training4,324,9993,664,5107,989,50954%46%

IMI126BTCUREInflammatory disorders17,362,87215,616,59532,979,46753%47%

IMI123QUIC-CONCEPTCancer7,000,0006,809,60613,809,60651%49%

IMI124RAPP-IDInfectious diseases6,828,4386,379,04813,207,48652%48%

IMI127DDMoReData Management10,399,42610,616,33621,015,76249%51%

IMI121PREDECTCancer8,756,6419,661,20118,417,84248%52%

IMI129EHR4CRData Management7,194,0447,555,88314,749,92749%51%

IMI128Open PHACTSData Management11,466,4336,412,90517,879,33864%36%

IMI122OncoTrackCancer16,757,28211,201,55727,958,83960%40%

IMI135EU-AIMSBrain disorders20,490,9819,773,54330,264,52468%32%

IMI132ABIRISKBiologicals18,170,2179,450,21127,620,42866%34%

IMI133BioVacSafeVaccines17,425,6647,999,68325,425,34769%31%

IMI136DIRECTMetabolic disorders21,388,64318,816,52740,205,17053%47%

IMI137EUPATIEducation and Training5,250,0005,701,17810,951,17848%52%

IMI131MIP-DILIDrug safety15,335,53812,648,46627,984,00455%45%

IMI134PreDiCT-TBInfectious diseases14,778,8559,296,10624,074,96161%39%

IMI145CHEM21Sustainable chemistry9,829,63813,871,77223,701,41041%59%

IMI143CompactBiologicals10,184,90918,217,73528,402,64436%64%

IMI147K4DDDrug kinetics8,286,9309,831,31818,118,24846%54%

IMI144OrBiToDrug delivery8,975,39212,360,85621,336,24842%58%

IMI141EMIF-ADBrain disorders12,178,42512,177,25224,355,67650%50%

IMI141EMIF- metabMetabolic disorders12,178,42512,177,25224,355,67650%50%

IMI146StemBANCCStem cells26,000,00020,761,38646,761,38656%44%

IMI142eTRIKSData Management10,309,81810,336,17820,645,99650%50%

IMI151EUCLIDDrug Discovery79,999,15791,337,070171,336,22747%53%

IMI161COMBACTEInfectious diseases109,433,01090,055,721199,488,73155%45%

IMI162TranslocationInfectious diseases15,984,2028,135,83324,120,03566%34%

IMI172GetRealRelative Efectiveness8,000,0006,910,39714,910,39754%46%

IMI171ADVANCEVaccines4,999,8115,017,35310,017,16450%50%

IMI183PRECISESADSInflammatory disorders9,999,3239,890,86519,890,18850%50%

IMI184AETIONOMYBrain disorders7,993,2348,021,46016,014,69450%50%

IMI185EBiSCStem cells21,840,3798,778,54630,618,92571%29%

IMI182ENABLEInfectious diseases58,900,00022,952,36081,852,36072%28%

IMI181APCInfectious diseases0ERROR:#DIV/0!ERROR:#DIV/0!

IMI191WEB-RADRDrug safety2,270,0002,754,0445,024,04445%55%

IMI192SPRINT-TGeriatrics23,999,43923,454,39247,453,83151%49%

IMI193Combacte-CareInfectious diseases23,871,50059,317,76083,189,26029%71%

IMI194DRIVE ABInfectious diseases6,299,9873,105,2509,405,23767%33%

IMI1101FLUCOPVaccines6,100,0006,100,20812,200,20850%50%

IMI1111APPROACHInflammatory disorders7,500,0007,499,99914,999,99950%50%

IMI1112EPADBrain disorders25,880,00030,204,98656,084,98646%54%

IMI1113Cancer IDCancer6,620,0007,565,69214,185,69247%53%

IMI1114ZAPIInfectious diseases9,538,6889,875,00019,413,68849%51%

IMI1115ULTRA-DDDrug Discovery21,200,00021,664,98142,864,98149%51%

IMI1116Combacte-MAGNETInfectious diseases75,340,00091,662,413167,002,41345%55%

IMI1117IABCInfectious diseases24,331,60925,550,02549,881,63449%51%

IMI1118IPIESustainable chemistry3,000,0005,698,2308,698,23034%66%

Sheet4

IMIIMI1

Call (All)

Row LabelsSum of IMI contribution euroSum of EFPIA contribution euroSum of Total contribution euroCount of IMI contribution euro

Infectious diseases34530628932632951667163580510

Drug Discovery1011991571130020512142012082

Brain disorders91416586.596822725.51882393127

Metabolic disorders56282386.563186487.51194688744

Drug safety55476820599067161153835366

Stem cells4784037929539932773803112

Cancer3913392335238056743719794

Data Management3936972134921302742910234

Inflammatory disorders3486219533007459678696543

Biologicals2835512627667946560230722

Vaccines2852547519117244476427193

Geriatrics2399943923454392474538311

Education and Training1916842820482070396504985

Lung diseases1670309821796269384993672

Sustainable chemistry1282963819570002323996402

Drug delivery897539212360856213362481

Drug kinetics82869309831318181182481

Relative Efectiveness80000006910397149103971

Grand Total965730983953144739191887572260

IMI 1 Charts

IMI1 projects

Interest areaIMI contributionEFPIA contribution Total contribution Percentage TotalNumber of projects

Infectious diseases345,306,289326,329,516671,635,80535%10

Drug Discovery101,199,157113,002,051214,201,20811%2

Brain disorders91,416,58796,822,726188,239,31310%7

Metabolic disorders56,282,38763,186,488119,468,8746%4

Drug safety55,476,82059,906,716115,383,5366%6

Stem cells47,840,37929,539,93277,380,3114%2

Cancer39,133,92335,238,05674,371,9794%4

Data Management39,369,72134,921,30274,291,0234%4

Inflammatory disorders34,862,19533,007,45967,869,6544%3

Biologicals28,355,12627,667,94656,023,0723%2

Vaccines28,525,47519,117,24447,642,7192%3

Geriatrics23,999,43923,454,39247,453,8312%1

Education and Training19,168,42820,482,07039,650,4982%5

Lung diseases16,703,09821,796,26938,499,3672%2

Sustainable chemistry12,829,63819,570,00232,399,6402%2

Drug Delivery8,975,39212,360,85621,336,2481%1

Drug kinetics8,286,9309,831,31818,118,2481%1

Relative Efectiveness8,000,0006,910,39714,910,3971%1

Grand Total965,730,983953,144,7391,918,875,722100%60

The total number of projects is 60 because project EMIF (IMI1 Call 4) has two areas of interest.

Legend:EFPIA contribution

IMI contribution

671 635 805

Infectious diseases - 35%


47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%

Lung diseases1670309821796269

32 399 640

Sustainable chemistry - 2%


39 650 498

Education and Training - 2%


18 118 248

Drug kinetics - 1%

Drug kinetics82869309831318

77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%

Biologicals2835512627667946

Drug Delivery -

21 336 248 - 1%

Drug Delivery897539212360856

14 910 397

Relative Efectiveness - 1%


214 201 208

Drug Discovery - 11%

Drug Discovery101199157113002051

188 239 313

Brain disorders - 10%

Brain disorders9141658796822726

115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874

Metabolic disorders - 6%


74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023

Data Management - 4%

Data Management3936972134921302

67 869 654

Inflammatory disorders - 4%


47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

671 635 805



47 453 831

Geriatrics - 2%

Geriatrics2399943923454392

38 499 367

Lung diseases - 2%


32 399 640



39 650 498



18 118 248

Drug kinetics - 1%


77 380 311

Stem cells - 4%

Stem cells4784037929539932

56 023 072

Biologicals - 3%


Drug Delivery -

21 336 248 - 1%


14 910 397



214 201 208



188 239 313



115 383 536

Drug safety - 6%

Drug safety5547682059906716

119 468 874



74 371 979

Cancer - 4%

Cancer3913392335238056

74 291 023



67 869 654



47 642 719

Vaccines - 2%

Vaccines2852547519117244

Infographics

Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459


Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459

IMI contributions

Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459

EFPIA contributions

Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459


Vaccines2852547519117244Geriatrics2399943923454392Lung diseases1670309821796269Sustainable chemistry1282963819570002Education and Training1916842820482070Stem cells4784037929539932Biologicals2835512627667946Drug kinetics82869309831318Drug Delivery897539212360856Relative Efectiveness80000006910397Infectious diseases345306289326329516Infectious diseases345306289326329516Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Drug Discovery101199157113002051Brain disorders9141658796822726Drug safety5547682059906716Metabolic disorders56282386.563186487.5Cancer3913392335238056Data Management3936972134921302Inflammatory disorders3486219533007459

IMI2 budget distribution per disease area

Distribution of funding per scientific areaUpdated February 2017

Infections control 316 925 777

48%IMI 2

Total contributions 663 895 301

Neurodegeneration 82 362 270

12%Other54 785 976 8%

Diabetes / metabolic desorders 64 576 544 10%

Translational safety 38 251 191 6%

Oncology 55 277 396 8%

IMI contributionsEFPIA contributions Associated partners contributions

Data and knowledge management 51 716 147 8 %

IMI2 projects

IMICall TopicProject AcronymScientific area main categoryScientific area subcategoryIMI contribution euroEFPIA contribution euroAssociated Partners contribution euroTotal contribution euroIMI contribution %EFPIA contribution %Associated Partners contribution %

IMI211INNODIADiabetes/metabolic desordersType 1 diabetes17,630,00012,745,1915,577,31635,952,50749%35%16%

IMI221VSV-EBOVACInfections controlVaccines3,887,260003,887,260100%0%0%

IMI221EBOVAC1Infections controlVaccines58,336,88533,745,758092,082,64363%37%0%

IMI221EBOVAC2Infections controlVaccines22,790,82013,880,240036,671,06062%38%0%

IMI225Mofina Infections control1,162,622001,162,622100%0%0%

IMI225FILODIAGInfections control2,260,105002,260,105100%0%0%

IMI225EbolaMoDRADInfections control4,300,935004,300,935100%0%0%

IMI222EBOMANInfections controlVaccines1,023,32547,642,879048,666,2042%98%0%

IMI224EBODACInfections controlVaccines20,328,8565,412,000025,740,85679%21%0%

IMI231RADAR-CNSData and knowledge managementPsychiatry AND Neurology AND Immunology AND Digital health11,000,00013,322,379024,322,37945%55%0%

IMI232RHAPSODYNeurodegenerationType 2 diabetes8,130,0006,882,049015,012,04954%46%0%

IMI233PRISMOtherPsychiatry AND Neurodegeneration8,080,0008,479,551016,559,55149%51%0%

IMI234VAC2VACInfections controlVaccines7,850,0008,128,429015,978,42949%51%0%

IMI235PERISCOPEInfections controlVaccines14,000,0007,125,1157,000,00028,125,11550%25%25%

IMI241ADAPT-SMARTOtherInnovative clinical paradigms 1,130,0001,979,13103,109,13136%64%0%

IMI251PREFEROtherInnovative clinical paradigms6,000,0006,000,000012,000,00050%50%0%

IMI252BEAt-DKDDiabetes/metabolic desordersDiabetic kidney disease15,085,93711,687,1001,851,00028,624,03753%41%6%

IMI253PHAGONeurodegenerationAlzheimer's disease8,838,0009,092,496017,930,49649%51%0%

IMI254AMYPADNeurodegenerationAlzheimer's disease11,999,88612,233,950024,233,83650%50%0%

IMI255MOPEADNeurodegenerationAlzheimer's disease2,043,0001,967,25104,010,25151%49%0%

IMI256ADAPTEDNeurodegenerationAlzheimer's disease3,510,0003,286,74006,796,74052%48%0%

IMI261TransQSTTranslational safety8,000,0007,802,874015,802,87451%49%0%

IMI262RESCEUInfections controlrespiratory diseases AND vaccines14,498,12514,673,665029,171,79050%50%0%

IMI263ROADMAPData and knowledge managementAlzheimer's disease and Data Knowledge Management (Big Data) 3,998,2503,768,72607,766,97651%49%0%

IMI264HARMONYOncologyCancer & Data Knowledge Management (Big Data)20,000,00019,294,265039,294,26551%49%0%

IMI271TRISTANTranslational safetyDrug safety12,000,00010,448,317022,448,31753%47%0%

IMI272IMPRINDNeurodegenerationAlzheimer's & Parkinson's disease 4,684,9986,365,900011,050,89842%58%0%

IMI273NGN-PETNeurodegenerationPain AND Aging related diseases1,500,0001,828,00003,328,00045%55%0%

IMI274MACUSTAROtherOphtalmology8,025,0007,937,644015,962,64450%50%0%

IMI275ITCC-P4OncologyCancer 7,370,0008,613,131015,983,13146%54%0%

IMI276DO-ITOther3,549,8333,604,81707,154,65050%50%0%

IMI277BigData4HeartData and knowledge managementCardiovascular disease and Data Knowledge Management (Big Data) 9,664,9709,961,822019,626,79249%51%0%

IMI281VSV-EBOPLUSInfections controlVaccines8,553,7507,208,545015,762,29554%46%0%

IMI281PEVIAInfections controlVaccines6,189,5706,926,893013,116,46347%53%0%

IMI291Clostridium difficileInfections controlantimicrobial resistance

IMI292Rheumatic DiseasesImmunologyImmune-mediated diseases

IMI293Data quality in pre-clinicalNeurodegenerationNeurodegeneration & Drug Safety

IMI294NEXGETSTranslational safety

IMI295LITMUSDiabetes/metabolic desordersNon alcoholic fatty liver disease

IMI296DRIVEInfections controlVaccines

IMI2101HypoglycaemiaDiabetes/metabolic desordersDiabetes

IMI2102Data for prostate cancerOncologyCancer and Data Knowledge Management (Big Data)

IMI2103Chronic painNeurodegenerationPain AND Aging related diseases

IMI2104Paediatric trial networkOtherPaediatric

IMI2105BiomanufacturingOther

IMI2106Solute carrierOther

IMI2107Patient perspectiveOtherInnovative clinical paradigms

IMI2108AutismOtherPsychiatry

Pies

Call (Multiple Items)

Row LabelsSum of IMI contribution euroSum of EFPIA contribution euroSum of Associated Partners contribution euroSum of Total contribution euroCount of Project Acronym

Infections control165182253144743523.657000000316925776.6513

Neurodegeneration40705884416563860823622707

Diabetes/metabolic desorders32715937244322917428316645765442

Oncology27370000279073960552773962

Other26784833280011430547859765

Data and knowledge management24663220270529270517161473

Translational safety20000000182511910382511912

Grand Total337422127312044857.6514428316663895300.6534

IMI 2 project by scientific area

IMI2 calls 1 to 8

Row LabelsIMI contribution euroEFPIA contribution euro Associated Partners contribution euroTotal contribution euroPercentage TotalNumber of projects

Infections control165,182,253144,743,5247,000,000316,925,77748%13

Neurodegeneration40,705,88441,656,386082,362,27012%7

Diabetes/metabolic desorders32,715,93724,432,2917,428,31664,576,54410%2

Oncology27,370,00027,907,396055,277,3968%2

Other26,784,83328,001,143054,785,9768%5

Data and knowledge management24,663,22027,052,927051,716,1478%3

Translational safety20,000,00018,251,191038,251,1916%2

Total337,422,127312,044,85814,428,316663,895,301100%34

316 925 777

Infections control - 48%

Infections control165182253144743523.650000017000000

82 362 270

Neurodegeneration - 12 %


64 576 544

Diabetes/metabolic desorders - 10%


55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147

Data and knowledge management - 8 %


38 251 191

Translational safety - 6 %


Total

[CELLRANGE][CELLRANGE], [CELLRANGE],

337422127312044857.6499999814428316IMI contribution euroEFPIA contribution euro Associated Partners contribution euro

316 925 777



82 362 270



64 576 544



55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147



38 251 191



Total



316 925 777



82 362 270



64 576 544



55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147



38 251 191



Total



316 925 777



82 362 270



64 576 544



55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147



38 251 191



Total



316 925 777



82 362 270



64 576 544



55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147



38 251 191



Total



316 925 777



82 362 270



64 576 544



55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147



38 251 191



Total



316 925 777



82 362 270



64 576 544



55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147



38 251 191



Total



316 925 777



82 362 270



64 576 544



55 277 396

Oncology - 8%

Oncology27370000279073960

54 785 976

Other 8%

Other26784833280011430

51 716 147



38 251 191



Total



Sheet1





Oncology27370000279073960

Other26784833280011430


Infections control 316 925 777 48%





Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430


Neurodegeneration 82 362 270 12%





Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430


Other54 785 976 8%





Oncology27370000279073960

Other26784833280011430


Diabetes / metabolic desorders 64 576 544 10%





Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430


Translational safety 38 251 191 6%





Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430


Oncology 55 277 396 8%





Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430






Oncology27370000279073960

Other26784833280011430


Data and knowledge management 51 716 147 8 %





Oncology27370000279073960

Other26784833280011430


ABIRISK - Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk www.abirisk.eu

MARCAR - Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis www.imi-marcar.eu/

eTOX - Integrating bioinformatics and chemoinformatics approaches for the development of Expert systems allowing the in silico prediction of toxicities www.e-tox.net

BIOVACSAFE - Biomarkers for Enhanced Vaccine Immunosafety www.biovacsafe.euSAFE-T - Safer and Faster Evidence-based Translation www.imi-safe-t.eu

MIP-DILI - Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury www.mip-dili.eu

TransQST - Translational quantitative systems toxicology to improve the understanding of the safety of medicines transqst.org

http://www.abirisk.eu/http://www.imi-marcar.eu/http://www.e-tox.net/http://www.biovacsafe.eu/http://www.imi-safe-t.eu/http://www.mip-dili.eu/http://transqst.org/

SafeSciMet - European Modular Education and Training Programme in Safety Sciences for Medicines www.safescimet.eu

WEB RADR - Recognising Adverse Drug Reactions web-radr.eu/

PREFER - Patient Preferences in benefit risk assessments during the drug life cycle imi-prefer.eu

PROTECT -Pharmacoepidemiological research on outcomes of therapeutics by a European consortium www.imi-protect.eu

EU2P - European programme in Pharmacovigilance and Pharmacoepidemiologywww.eu2p.org

iPIE - Intelligent Assessment of Pharmaceuticals in the Environment www.i-pie.org

http://www.safescimet.eu/http://web-radr.eu/http://www.imi-protect.eu/http://www.eu2p.org/http://www.i-pie.org/

Stay in touch

Visit our website www.imi.europa.eu

Sign up to our newsletter bit.ly/IMInewsletter

Follow us on Twitter @IMI_JU

Join our LinkedIn groupbit.ly/LinkedInIMI

E-mail [email protected]

Thank you

Hugh Laverty Head of Scientific Operations

[email protected]

Slide Number 1IMI Europes partnership for healthGoals of IMI 2 programmeIMI key conceptsAn international, cross-sector communityIMI1 budget distribution per disease areaIMI2 budget distribution per disease areaABIRISK - Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk www.abirisk.eu Slide Number 9Stay in touchSlide Number 11

The Innovative Medicines Initiative - ILSI Health and...

Documents

Transcript of The Innovative Medicines Initiative - ILSI Health and...